|
Psychopharmacology
Citations 51-60 of 175 total displayed.
|
Past content
(since Feb 1998):
|
- Original Articles
Comparing Drug-Related Hospital Morbidity Following Heroin Dependence Treatment With Methadone Maintenance or Naltrexone Implantation
- Hanh T. T. Ngo; Robert J. Tait; Gary K. Hulse
Arch Gen Psychiatry 2008; 65: 457-465.
[Abstract]
[Full text]
[PDF]
[ eTable ]
- Original Articles
Effect of Naltrexone and Ondansetron on Alcohol Cue–Induced Activation of the Ventral Striatum in Alcohol-Dependent People
- Hugh Myrick; Raymond F. Anton; Xingbao Li; Scott Henderson; Patrick K. Randall; Konstantin Voronin
Arch Gen Psychiatry 2008; 65: 466-475.
[Abstract]
[Full text]
[PDF]
- Commentaries
Clinical Trials in Bipolar Mania: Implications in Study Design and Drug Development
- Mauricio Tohen
Arch Gen Psychiatry 2008; 65: 252-253.
[Extract]
[Full text]
[PDF]
- Original Articles
Protein Kinase C Inhibition in the Treatment of Mania: A Double-blind, Placebo-Controlled Trial of Tamoxifen
- Aysegül Yildiz; Sebnem Guleryuz; Donna Pauler Ankerst; Dost Öngür; Perry F. Renshaw
Arch Gen Psychiatry 2008; 65: 255-263.
[Abstract]
[Full text]
[PDF]
- Commentaries
Prospects for a Genomic Approach to the Treatment of Alcoholism
- Charles P. O’Brien
Arch Gen Psychiatry 2008; 65: 132-133.
[Extract]
[Full text]
[PDF]
- Original Articles
An Evaluation of µ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol Dependence: Results From the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study
- Raymond F. Anton; Gabor Oroszi; Stephanie O’Malley; David Couper; Robert Swift; Helen Pettinati; David Goldman
Arch Gen Psychiatry 2008; 65: 135-144.
[Abstract]
[Full text]
[PDF]
- Letters to the Editor
Is Psychosocial Management Effective?
- Sahoo Saddichha; Devvarta Kumar
Arch Gen Psychiatry 2007; 64: 1451-a.
[Extract]
[Full text]
[PDF]
- Letters to the Editor
Is Psychosocial Management Effective?—Reply
- David J. Miklowitz; Michael W. Otto; Ellen Frank; Noreen A. Reilly-Harrington; Stephen R. Wisniewski; Jane N. Kogan; Andrew A. Nierenberg; Joseph R. Calabrese; Lauren B. Marangell; Laszlo Gyulai; Mako Araga; Jodi M. Gonzalez; Edwin R. Shirley; Michael E. Thase; Gary S. Sachs
Arch Gen Psychiatry 2007; 64: 1452-1453.
[Extract]
[Full text]
[PDF]
- Original Articles
Cost-Benefit Analysis of Second-Generation Antipsychotics and Placebo in a Randomized Trial of the Treatment of Psychosis and Aggression in Alzheimer Disease
- Robert A. Rosenheck; Douglas L. Leslie; Jody L. Sindelar; Edward A. Miller; Peter N. Tariot; Karen S. Dagerman; Sonia M. Davis; Barry D. Lebowitz; Peter Rabins; John K. Hsiao; Jeffery A. Lieberman; Lon S. Schneider; for the Clinical Antipsychotic Trial of Intervention Effectiveness–Alzheimer's Disease (CATIE-AD) investigators
Arch Gen Psychiatry 2007; 64: 1259-1268.
[Abstract]
[Full text]
[PDF]
- Original Articles
Cognitive Improvement After Treatment With Second-Generation Antipsychotic Medications in First-Episode Schizophrenia: Is It a Practice Effect?
- Terry E. Goldberg; Robert S. Goldman; Katherine E. Burdick; Anil K. Malhotra; Todd Lencz; Raman C. Patel; Margaret G. Woerner; Nina R. Schooler; John M. Kane; Delbert G. Robinson
Arch Gen Psychiatry 2007; 64: 1115-1122.
[Abstract]
[Full text]
[PDF]
|
|
